Novel Application of Microdosing Glucagon for Hypoglycemia After Total Pancreatectomy and Autologous Islet Transplant
Total pancreatectomy and autologous islet transplantation (TPAIT) is a procedure to ameliorate dysglycemia associated with post-pancreatectomy. Patients who undergo TPAIT are at risk of developing hypoglycemia postoperatively. The current literature suggests that hypoglycemia may be due to a glucago...
Gespeichert in:
Veröffentlicht in: | JCEM case reports 2024, Vol.2 (1), p.luad171-luad171 |
---|---|
Hauptverfasser: | , , |
Format: | Report |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | luad171 |
---|---|
container_issue | 1 |
container_start_page | luad171 |
container_title | JCEM case reports |
container_volume | 2 |
creator | Rafi, Ebne Lewis, Claudia Hatipoglu, Betul |
description | Total pancreatectomy and autologous islet transplantation (TPAIT) is a procedure to ameliorate dysglycemia associated with post-pancreatectomy. Patients who undergo TPAIT are at risk of developing hypoglycemia postoperatively. The current literature suggests that hypoglycemia may be due to a glucagon-deficiency state. To date, there is minimal literature available that explores treatment options to minimize hypoglycemia in these patients. In this case, a 29-year-old female patient was administered a microdosing glucagon protocol post TPAIT and experienced improvements in hypoglycemia. We describe the dosing regimen of the protocol and provide continuous glucose monitoring data to support our findings. This case adds to the limited evidence on effective treatment options for these rare patients. To our knowledge, this is the first application of a microdosing glucagon protocol to treat hypoglycemia associated with TPAIT. |
doi_str_mv | 10.1210/jcemcr/luad171 |
format | Report |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_2928957197</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2928957197</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_29289571973</originalsourceid><addsrcrecordid>eNqVjb1qwzAURkWhkNBm7XzHLmkkFaNoNKVtOrRk8B4usmwUrnVd_RT89vXQF-h04ON8HCEelHxSWsnD1fnJpQNV7JVRN2KrTdPsVaPlRuxyvkoptbXSGr0V9Yt_PEE7zxQclsAReIDP4BL3nEMc4Z2qw3HdB05wWmYeaVkDAaEdik_QcUGCM0aXPBbvCk8LYOyhrYWJR64ZPjL5Al3CmGfCWO7F7YCU_e6Pd-Lx7bV7Oe3nxN_V53KZQnaeVtev_4u2-mgbo6x5_of6C7dKWBk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype><pqid>2928957197</pqid></control><display><type>report</type><title>Novel Application of Microdosing Glucagon for Hypoglycemia After Total Pancreatectomy and Autologous Islet Transplant</title><source>Oxford Journals Open Access Collection</source><source>PMC (PubMed Central)</source><creator>Rafi, Ebne ; Lewis, Claudia ; Hatipoglu, Betul</creator><creatorcontrib>Rafi, Ebne ; Lewis, Claudia ; Hatipoglu, Betul</creatorcontrib><description>Total pancreatectomy and autologous islet transplantation (TPAIT) is a procedure to ameliorate dysglycemia associated with post-pancreatectomy. Patients who undergo TPAIT are at risk of developing hypoglycemia postoperatively. The current literature suggests that hypoglycemia may be due to a glucagon-deficiency state. To date, there is minimal literature available that explores treatment options to minimize hypoglycemia in these patients. In this case, a 29-year-old female patient was administered a microdosing glucagon protocol post TPAIT and experienced improvements in hypoglycemia. We describe the dosing regimen of the protocol and provide continuous glucose monitoring data to support our findings. This case adds to the limited evidence on effective treatment options for these rare patients. To our knowledge, this is the first application of a microdosing glucagon protocol to treat hypoglycemia associated with TPAIT.</description><identifier>EISSN: 2755-1520</identifier><identifier>DOI: 10.1210/jcemcr/luad171</identifier><language>eng</language><ispartof>JCEM case reports, 2024, Vol.2 (1), p.luad171-luad171</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>780,784,4490,27925</link.rule.ids></links><search><creatorcontrib>Rafi, Ebne</creatorcontrib><creatorcontrib>Lewis, Claudia</creatorcontrib><creatorcontrib>Hatipoglu, Betul</creatorcontrib><title>Novel Application of Microdosing Glucagon for Hypoglycemia After Total Pancreatectomy and Autologous Islet Transplant</title><title>JCEM case reports</title><description>Total pancreatectomy and autologous islet transplantation (TPAIT) is a procedure to ameliorate dysglycemia associated with post-pancreatectomy. Patients who undergo TPAIT are at risk of developing hypoglycemia postoperatively. The current literature suggests that hypoglycemia may be due to a glucagon-deficiency state. To date, there is minimal literature available that explores treatment options to minimize hypoglycemia in these patients. In this case, a 29-year-old female patient was administered a microdosing glucagon protocol post TPAIT and experienced improvements in hypoglycemia. We describe the dosing regimen of the protocol and provide continuous glucose monitoring data to support our findings. This case adds to the limited evidence on effective treatment options for these rare patients. To our knowledge, this is the first application of a microdosing glucagon protocol to treat hypoglycemia associated with TPAIT.</description><issn>2755-1520</issn><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2024</creationdate><recordtype>report</recordtype><recordid>eNqVjb1qwzAURkWhkNBm7XzHLmkkFaNoNKVtOrRk8B4usmwUrnVd_RT89vXQF-h04ON8HCEelHxSWsnD1fnJpQNV7JVRN2KrTdPsVaPlRuxyvkoptbXSGr0V9Yt_PEE7zxQclsAReIDP4BL3nEMc4Z2qw3HdB05wWmYeaVkDAaEdik_QcUGCM0aXPBbvCk8LYOyhrYWJR64ZPjL5Al3CmGfCWO7F7YCU_e6Pd-Lx7bV7Oe3nxN_V53KZQnaeVtev_4u2-mgbo6x5_of6C7dKWBk</recordid><startdate>20240101</startdate><enddate>20240101</enddate><creator>Rafi, Ebne</creator><creator>Lewis, Claudia</creator><creator>Hatipoglu, Betul</creator><scope>7X8</scope></search><sort><creationdate>20240101</creationdate><title>Novel Application of Microdosing Glucagon for Hypoglycemia After Total Pancreatectomy and Autologous Islet Transplant</title><author>Rafi, Ebne ; Lewis, Claudia ; Hatipoglu, Betul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_29289571973</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Rafi, Ebne</creatorcontrib><creatorcontrib>Lewis, Claudia</creatorcontrib><creatorcontrib>Hatipoglu, Betul</creatorcontrib><collection>MEDLINE - Academic</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rafi, Ebne</au><au>Lewis, Claudia</au><au>Hatipoglu, Betul</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><atitle>Novel Application of Microdosing Glucagon for Hypoglycemia After Total Pancreatectomy and Autologous Islet Transplant</atitle><jtitle>JCEM case reports</jtitle><date>2024-01-01</date><risdate>2024</risdate><volume>2</volume><issue>1</issue><spage>luad171</spage><epage>luad171</epage><pages>luad171-luad171</pages><eissn>2755-1520</eissn><abstract>Total pancreatectomy and autologous islet transplantation (TPAIT) is a procedure to ameliorate dysglycemia associated with post-pancreatectomy. Patients who undergo TPAIT are at risk of developing hypoglycemia postoperatively. The current literature suggests that hypoglycemia may be due to a glucagon-deficiency state. To date, there is minimal literature available that explores treatment options to minimize hypoglycemia in these patients. In this case, a 29-year-old female patient was administered a microdosing glucagon protocol post TPAIT and experienced improvements in hypoglycemia. We describe the dosing regimen of the protocol and provide continuous glucose monitoring data to support our findings. This case adds to the limited evidence on effective treatment options for these rare patients. To our knowledge, this is the first application of a microdosing glucagon protocol to treat hypoglycemia associated with TPAIT.</abstract><doi>10.1210/jcemcr/luad171</doi></addata></record> |
fulltext | fulltext |
identifier | EISSN: 2755-1520 |
ispartof | JCEM case reports, 2024, Vol.2 (1), p.luad171-luad171 |
issn | 2755-1520 |
language | eng |
recordid | cdi_proquest_miscellaneous_2928957197 |
source | Oxford Journals Open Access Collection; PMC (PubMed Central) |
title | Novel Application of Microdosing Glucagon for Hypoglycemia After Total Pancreatectomy and Autologous Islet Transplant |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T18%3A35%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=Novel%20Application%20of%20Microdosing%20Glucagon%20for%20Hypoglycemia%20After%20Total%20Pancreatectomy%20and%20Autologous%20Islet%20Transplant&rft.jtitle=JCEM%20case%20reports&rft.au=Rafi,%20Ebne&rft.date=2024-01-01&rft.volume=2&rft.issue=1&rft.spage=luad171&rft.epage=luad171&rft.pages=luad171-luad171&rft.eissn=2755-1520&rft_id=info:doi/10.1210/jcemcr/luad171&rft_dat=%3Cproquest%3E2928957197%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2928957197&rft_id=info:pmid/&rfr_iscdi=true |